Newer atypical antipsychotic medication in comparison to clozapine: a systematic review of randomized trials
- 17 June 2002
- journal article
- research article
- Published by Elsevier in Schizophrenia Research
- Vol. 56 (1-2) , 1-10
- https://doi.org/10.1016/s0920-9964(01)00212-2
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Is olanzapine a substitute for clozapine? The effects on psychomotor performanceSchizophrenia Research, 2000
- Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?Published by Elsevier ,1998
- New antipsychotic medications: strategies for evaluation and selected findingsSchizophrenia Research, 1997
- Improvement of Cognitive Function in Schizophrenic Patients Receiving Clozapine or Zotepine: Results from a Double-Blind StudyPharmacopsychiatry, 1997
- Treatment-resistant schizophrenia: clinical experience with new antipsychoticsEuropean Neuropsychopharmacology, 1996
- New AntipsychoticsCNS Drugs, 1996
- P-4-73 A randomized double-bind trial of risperidone versus clozapine for treatment-resistant chronic schizophreniaEuropean Neuropsychopharmacology, 1995
- The tolerabilitv and efficacv of the atypical neuroleptic remoxipride cokpared with clozapine and haloperidol in acute schizophreniaActa Psychiatrica Scandinavica, 1994
- The New Atypical AntipsychoticsThe British Journal of Psychiatry, 1994
- Meta-Analyses of Randomized Controlled TrialsNew England Journal of Medicine, 1987